Gupta Sudipti, Nicassio Lauren, Junquera Guillermo Yepes, Jackson Ashley R, Fuchs Molly, McLeod Daryl, Alpert Seth, Jayanthi Venkata R, DaJusta Daniel, McHugh Kirk M, Becknell Brian, Ching Christina B
Division of Pediatric Urology, Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, USA; Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Division of Pediatric Urology, Department of Pediatric Surgery, Nationwide Children's Hospital, Columbus, OH, USA.
J Pediatr Urol. 2020 Oct;16(5):592.e1-592.e7. doi: 10.1016/j.jpurol.2020.03.006. Epub 2020 Mar 29.
In the pediatric patient whose ureteropelvic junction obstruction (UPJO) is not always symptomatic, imaging is the most common means of detecting surgical success. There is interest, however, in other means of post-operative monitoring. A panel of antimicrobial peptides (AMPs) has been previously found to be elevated in UPJO, but the impact of surgical correction on these AMPs is unknown.
To determine if elevated levels of candidate urinary AMP biomarkers of urinary tract obstruction decrease following UPJO repair.
Pediatric patients undergoing surgical correction of an UPJO were recruited for participation. Bladder urine from uninfected consenting/assenting patients was collected immediately prior to surgery and then at least 6 months afterward. Based on prior studies demonstrating significant elevation of beta defensin 1 (BD-1), hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP), cathelicidin (LL-37), and neutrophil gelatinase-associated lipocalin (NGAL) in patients with UPJO versus control patients, we performed enzyme-linked immunosorbent assays on these four AMPs to compare their expression before and after surgical intervention. If found to significantly decrease, AMP levels were compared to healthy controls. AMP levels were normalized to urine creatinine. Results were analyzed with paired t test or Wilcoxon test using Graphpad software. Correlation was calculated using Pearson or Spearman correlation. A p-value of <0.05 was considered significant.
13 UPJO patients were included in this study; 9 were male (69%). Age at surgery was a median of 4.3 years (average 6.1, range 0.4-18.4 years). Follow-up urine samples were collected a median of 27.4 months after surgery (average 27.4; range 7.8-45.3 months). All 13 patients had clinical improvement and/or signs of improved hydronephrosis on post-operative imaging. HIP/PAP and BD-1 significantly decreased in post-surgical samples compared to pre-surgical samples (p = 0.02 and 0.01, respectively); NGAL and LL-37 did not significantly change. Overall, HIP/PAP decreased in 12 patients (92%) and BD-1 decreased in 11 patients (85%). BD-1 levels after successful repair were not different from healthy controls (p = 0.06).
Urinary biomarkers of obstruction should detect significant obstructive pathology as well as reflect its resolution. This would enable their use in post-operative monitoring and augment current methods of determining successful surgical outcome through imaging.
The AMPs HIP/PAP and BD-1 are significantly elevated in UPJO but then significantly decrease after pyeloplasty, with BD-1 returning to healthy control levels. As a result, these AMPs could serve as markers of successful surgical intervention.
在输尿管肾盂连接部梗阻(UPJO)并非总是有症状的儿科患者中,影像学检查是检测手术成功与否最常用的方法。然而,人们对术后监测的其他方法也很感兴趣。先前发现一组抗菌肽(AMPs)在UPJO患者中升高,但手术矫正对这些抗菌肽的影响尚不清楚。
确定尿路梗阻候选尿AMPs生物标志物水平在UPJO修复后是否降低。
招募接受UPJO手术矫正的儿科患者参与研究。在手术前及术后至少6个月,收集未感染且同意参与的患者的膀胱尿液。基于先前研究表明,与对照患者相比,UPJO患者中β-防御素1(BD-1)、肝癌-肠-胰腺/胰腺炎相关蛋白(HIP/PAP)、杀菌肽(LL-37)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)显著升高,我们对这四种抗菌肽进行酶联免疫吸附测定,以比较手术干预前后它们的表达情况。如果发现显著降低,则将抗菌肽水平与健康对照进行比较。抗菌肽水平以尿肌酐进行标准化。使用Graphpad软件通过配对t检验或Wilcoxon检验分析结果。使用Pearson或Spearman相关性计算相关性。p值<0.05被认为具有统计学意义。
本研究纳入13例UPJO患者;9例为男性(69%)。手术年龄中位数为4.3岁(平均6.1岁;范围0.4 - 18.4岁)。术后尿液样本收集时间中位数为术后27.4个月(平均27.4个月;范围7.8 - 45.3个月)。所有13例患者临床症状均有改善和/或术后影像学检查显示肾盂积水改善迹象。与术前样本相比,术后样本中HIP/PAP和BD-1显著降低(p分别为0.02和0.01);NGAL和LL-37无显著变化。总体而言,12例患者(92%)的HIP/PAP降低,11例患者(85%)的BD-1降低。成功修复后BD-1水平与健康对照无差异(p = 0.06)。
梗阻性尿路生物标志物应能检测出显著的梗阻性病变并反映其缓解情况。这将使其可用于术后监测,并增强目前通过影像学确定手术成功结果的方法。
抗菌肽HIP/PAP和BD-1在UPJO中显著升高,但肾盂成形术后显著降低,且BD-1恢复至健康对照水平。因此,这些抗菌肽可作为手术成功干预的标志物。